Clinical Scorecard: Efficacy of Photon-Counting Detector CT Iodine Mapping for Detecting Myocardial Late Enhancement

At a Glance

Key Highlights

• LGE cardiac MRI is the established reference standard for detecting myocardial fibrosis and late enhancement but has limitations including time consumption, artifacts, contraindications, and patient cooperation challenges.
• PCD-CT offers improved spatial resolution, elimination of electronic noise, and spectral imaging capabilities enabling iodine quantification maps comparable to MRI for extracellular volume assessment.
• Iodine maps from PCD-CT can suppress surrounding soft tissue and highlight contrast-enhanced myocardial regions, potentially serving as an alternative for LIE detection.

Guideline-Based Recommendations

Diagnosis

• Use LGE cardiac MRI as the reference standard for myocardial late enhancement detection.
• Consider PCD-CT iodine mapping as a complementary or alternative imaging modality when MRI is contraindicated or not feasible.

Management

• Employ PCD-CT iodine maps to assess myocardial fibrosis and late enhancement in patients undergoing cardiac evaluation.
• Use delayed phase PCD-CT imaging approximately 5 minutes post-iodine contrast administration for optimal LIE visualization.

Monitoring & Follow-up

• Perform blinded, independent image review by experienced cardiac radiologists to assess image quality and enhancement patterns.
• Evaluate subjective image quality parameters including noise, sharpness, and overall image quality using standardized scales.

Risks

• Be aware of contraindications to iodine-based contrast media before PCD-CT imaging.
• Consider radiation exposure associated with CT imaging when selecting diagnostic modalities.

Patient & Prescribing Data

Adults undergoing cardiac MRI for clinical indications, with same-day PCD-CT imaging.

Iodinated contrast media (100 mL iopromide, 370 mg I/mL) administered intravenously followed by saline chaser; PCD-CT delayed phase imaging performed 5 minutes post-contrast.

Clinical Best Practices

• Ensure patient eligibility by screening for contraindications to iodine contrast and MRI prior to imaging.
• Use standardized imaging protocols for both LGE MRI and PCD-CT to enable accurate comparison and assessment.
• Apply iterative reconstruction and quantitative kernels during PCD-CT image processing to optimize iodine map quality.
• Conduct image interpretation by experienced, blinded radiologists to reduce bias and improve diagnostic accuracy.

References

• Clinical guidelines on LGE cardiac MRI
• Photon-counting detector CT technology and applications
• Comparison of iodine mapping and LGE MRI for myocardial fibrosis